AI-generated summary
The authors ran a pilot study using a single-case design with repeated measures to test whether photobiomodulation could be applied safely and affect symptoms of overactive bladder. They report no adverse events and unchanged blood pressure, and that urinary frequency improved during treatment and at follow-up. The authors suggest a controlled trial is warranted.
- Who or what was studied
- Patients with overactive bladder (OAB) symptoms
- Limits stated in the abstract
- The abstract describes a pilot single-case design with no controlled comparison and does not state the number of participants.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on polscientific.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Pilot study, Effect size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.